Novo Nordisk A/S is poised for long-term growth despite job cuts and margin resets. Click here to find out why NVO stock is a ...

The rapid rise in prescriptions for GLP-1 weight loss drugs had a muted effect on Delaware health insurers’ spending thanks ...

CVS Caremark is facing a lawsuit after being accused of pointing patients to use a weight loss drug called Wegovy and for ...

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s ...

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

Critical decisions are too often made not by doctors in consultation with their patients, but behind closed doors between ...

A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. | A new ...

A class-action lawsuit filed against CVS Caremark argues that the PBM dropping coverage of Zepbound for Wegovy is illegal.

Two New York residents have filed a lawsuit against CVS after the company’s pharmacy benefit manager, Caremark, denied coverage for Zepbound in favor of Wegovy. The plaintiffs — Dennis Larkin of ...

A class action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lily’s ...